Journal
JOURNAL OF ORGANIC CHEMISTRY
Volume 80, Issue 20, Pages 10076-10085Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.joc.5b01703
Keywords
-
Categories
Funding
- NIH
- General Medical Sciences [R01 GM090082, P41 GM08915]
- Curza
- Amgen
- Eli Lilly
- NIH, National Cancer Institute [R01 CA140296]
Ask authors/readers for more resources
A short and scalable synthesis of naamidine A, a marine alkaloid with a selective ability to inhibit epidermal growth factor receptor (EGFR)-dependent cellular proliferation, has been achieved. A key achievement in this synthesis was the development of a regioselective hydroamination of a monoprotected propargylguanidine to deliver N-3-protected cyclic ene-guanidines. This permits the extension of this methodology to prepare N-2-acyl analogues in a fashion that obviates the troublesome acylation of the free 2-aminoimidazoles, which typically yields mixtures of N-2- and N-2,N-2-diacylated products.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available